Immediate Impact
59 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Current status and future trends of the global burden of MASLD
2024 Standout
Works of Huapeng Lin being referenced
Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease
2022
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Huapeng Lin | 335 | 302 | 216 | 257 | 51 | 793 | |
| Jae Hyun Han | 221 | 255 | 157 | 215 | 46 | 892 | |
| Rajiv Lochan | 381 | 341 | 294 | 301 | 30 | 860 | |
| Ciro Celsa | 395 | 206 | 314 | 209 | 56 | 706 | |
| Alessandro Uzzau | 138 | 428 | 196 | 146 | 47 | 782 | |
| Jesús Villar | 131 | 491 | 119 | 191 | 82 | 872 | |
| Steen Antonsen | 307 | 176 | 186 | 99 | 56 | 809 | |
| Thoetchai Peeraphatdit | 225 | 202 | 171 | 183 | 37 | 681 | |
| Kwang Min Kim | 307 | 358 | 130 | 367 | 62 | 858 | |
| Fabian Kütting | 370 | 173 | 128 | 112 | 26 | 688 | |
| Rajni Yadav | 265 | 236 | 114 | 133 | 103 | 743 |
All Works
Login with ORCID to disown or claim papers
Loading papers...